Last update 08 May 2025

CD38 x NAD+

Basic Info

Related Targets
CD38NAD+

Related

1
Drugs associated with CD38 x NAD+
IPG-8294
Target
CD38 x Hydrolase x NAD+
Mechanism
CD38 inhibitors [+2]
Active Org.
Nanjing Immunophage Biotech Co. Ltd.Nanjing Immunophage Biotech Co. Ltd.
Originator Org.
Nanjing Immunophage Biotech Co. Ltd.Nanjing Immunophage Biotech Co. Ltd.
Active Indication
Alzheimer Disease [+2]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with CD38 x NAD+
Login to view more data
100 Translational Medicine associated with CD38 x NAD+
Login to view more data
0 Patents (Medical) associated with CD38 x NAD+
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free